Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats - Wikidata - awgldk - TriplyDB

Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats

Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats

http://www.wikidata.org/entity/Q35691575

about

Wt-1 Expression Linked to Nitric Oxide Availability during Neonatal Obstructive Nephropathy The Lipid lowering and Onset of Renal Disease (LORD) Trial: a randomized double blind placebo controlled trial assessing the effect of atorvastatin on the progression of kidney disease.Simvastatin decreases endothelial progenitor cell apoptosis in the kidney of hypertensive hypercholesterolemic pigs Evaluation of metalloprotease inhibitors on hypertension and diabetic nephropathy.Rosuvastatin attenuates contrast-induced nephropathy through modulation of nitric oxide, inflammatory responses, oxidative stress and apoptosis in diabetic male rats Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.Role of WNT10A-expressing kidney fibroblasts in acute interstitial nephritis.Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-beta, and fibronectin with concomitant increase in nitric oxide bioavailability Amelioration of cisplatin-induced nephrotoxicity by statins.An overview of the extra-lipid effects of rosuvastatin.Simvastatin and tempol protect against endothelial dysfunction and renal injury in a model of obesity and hypertension.Pravastatin versus simvastatin for prevention of contrast-induced nephropathy.Cathepsin L activity correlates with proteinuria in chronic kidney disease in humans.Rodent Models of Vascular Cognitive Impairment.Rosuvastatin added to standard heart failure therapy improves cardiac remodelling in heart failure rats with preserved ejection fraction.Effect of targeting mitogen-activated protein kinase on cardiac remodeling in rats.Is the SHRSP [corrected] strain a suitable model of spontaneous CADASIL?Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats.Adipose tissue-derived stem cell treatment prevents renal disease progression.

P2860

Q26851512-E432DF80-3C40-4A46-A477-2ED0E433145A Q33325660-80BEB238-510D-4B4C-8DA8-2ADC7A728296 Q33835733-1FC14CF6-561C-40E7-A1A2-5FD77C6E59C7 Q34784085-EC3E8845-0580-4177-B1EC-9BB80B01E68E Q35085628-9D3CE7CF-1DFF-41B0-BC3D-73396520A384 Q35107757-6306D3C0-0220-4311-A0A7-F9DEEC03B09F Q35211510-9D6C4E4B-7785-4DA3-A463-7A4F5CC87DE6 Q36807095-9B490976-5C71-4DCA-AE8C-AFCC5D74FB8B Q37133302-A5DA1A6E-E1DF-4DBE-838D-DA74041E944E Q37156139-02DCE405-1CE4-4E43-8166-0CA220C8BB78 Q37174513-8F4EC1F5-5893-42B0-8567-1055C1FF51DB Q37850896-A5687553-07D3-4FAF-B6CE-D3B3D88F4AA3 Q38680372-D564CCC6-33D6-43F9-A4F0-6CC956E39185 Q38920987-A8773AC9-4E6F-455E-BBE3-19FBB80F0AAA Q42986839-1971BD18-4698-4613-844C-853D708883E5 Q43244751-CEFBB1A0-BFEF-49F9-8FBB-2DC8C0E76B1B Q48969813-0C8A4438-3A8F-4172-B7A0-03CA1FEBFB7A Q50497309-73A0C983-C0B5-4056-8A42-09145CBE1DF7 Q53187823-65E7B653-F881-445B-8674-7E3A36A1879F

P2860

Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats

http://www.wikidata.org/entity/Q35691575

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Rosuvastatin treatment prevent ...... fibrosis in stroke-prone rats

@ast

Rosuvastatin treatment prevent ...... fibrosis in stroke-prone rats

@en

type

label

Rosuvastatin treatment prevent ...... fibrosis in stroke-prone rats

@ast

Rosuvastatin treatment prevent ...... fibrosis in stroke-prone rats

@en

prefLabel

Rosuvastatin treatment prevent ...... fibrosis in stroke-prone rats

@ast

Rosuvastatin treatment prevent ...... fibrosis in stroke-prone rats

@en

P1433

Q35691575-5D29BD0B-D610-490D-96D4-B229A9821578

P1476

Q35691575-048ADF0B-7E61-4E8C-AD40-3389EA94BA3B

P2093

Q35691575-0B74BFE5-A84B-4C19-BC05-17491FD08D38

Q35691575-203CD464-7D51-4964-91A4-8135E7E401BA

Q35691575-2DDA2A37-F808-49D2-8927-661BCF1C1C60

Q35691575-6F623D8A-9275-4D84-9B29-106CFA05EB00

Q35691575-7CA2D94E-08CD-46F4-81AF-1B4C5925BE99

Q35691575-A7608F54-A3BA-468E-9648-1E6C941CD73D

Q35691575-CBC16425-A564-4DDF-98FB-532F30D1BCB8

Q35691575-D4F79136-C2F6-4E27-B30A-8AE713BB0C4A

Q35691575-EB3B983C-9859-400A-B632-FE05B1CE798A

P2860

Q35691575-0B9E5267-05A6-4462-9651-A02174EF4FA9

Q35691575-0DAD3711-4537-424F-812E-5CCA00976C21

Q35691575-1094FAE9-A6E5-4765-BE8E-97E9D052C56D

Q35691575-1B6ECA21-44B2-42EA-8A8D-7E7E8A25EAB3

Q35691575-1BA12F31-6CF2-4491-A29C-EB32C347E93B

Q35691575-1F00D35B-35B1-4DCD-9D0A-B164B9CB05BE

Q35691575-247B36F6-E4A4-4A68-AF45-BB04281D2D53

Q35691575-2853635D-6C9E-467F-96F3-5BC3AF7CEF85

Q35691575-303D271C-93D7-4580-A624-0E98434ECCDF

Q35691575-3CC1550D-AF95-40EE-B688-476533832FBA

P304

Q35691575-5D8E7127-3666-4E3A-B608-129E6900F12D

P31

Q35691575-CEE40F14-C05C-4B80-A104-51F7E8A8DBD4

P356

Q35691575-47F6FC26-E409-4567-A601-7D1935A58A73

P407

Q35691575-22ADC74E-81C2-4A98-9AA4-4E5456DFC380

P433

Q35691575-5C5DD791-6F34-4B9C-A95E-097DFCD7710A

P478

Q35691575-1768C0F2-E7BA-460A-8274-4AF97F51A49A

P50

Q35691575-45F3DADD-958E-4513-BA24-1A938846C9EB

Q35691575-6CF79EEA-14B7-47AE-B7E1-4877860F8C75

Q35691575-6F443B83-63D1-4F51-B3EE-F7C6932DAC93

Q35691575-80AF16FA-B5B8-471C-8ECA-BDF65ED17AD2

Q35691575-D9B20860-B128-45EE-A751-571773B3B8EA

Q35691575-E51A1402-6D2A-4086-8472-69F2663A58F1

P577

Q35691575-2F5883DD-6803-4307-93DD-912A74991D34

P5875

Q35691575-43817A5D-9BB5-4677-B6BF-2CC8E2B55446

P698

Q35691575-D75CC4A3-F2B5-4B0C-8FC9-A6197617BAD3

P932

Q35691575-011F46B7-E3FA-4422-8E25-447A89F9F2F8

P356

AJPATH.2007.060882

P1433

The American Journal of Pathology

P1476

Rosuvastatin treatment prevent ...... fibrosis in stroke-prone rats

@en

P2093

Anita Gianella

http://www.w3.org/2001/XMLSchema#string

Carla Zoja

http://www.w3.org/2001/XMLSchema#string

Daniela Rottoli

http://www.w3.org/2001/XMLSchema#string

Elena Nobili

http://www.w3.org/2001/XMLSchema#string

Luciana Mussoni

http://www.w3.org/2001/XMLSchema#string

Mauro Abbate

http://www.w3.org/2001/XMLSchema#string

Monica Canavesi

http://www.w3.org/2001/XMLSchema#string

Stefano Bellosta

http://www.w3.org/2001/XMLSchema#string

Uliano Guerrini

http://www.w3.org/2001/XMLSchema#string

P2860

Acute-phase proteins before cerebral ischemia in stroke-prone rats: identification by proteomics

New insights into brain damage in stroke-prone rats: a nuclear magnetic imaging study.

Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.

Plasminogen activator inhibitor-1 and the kidney.

Clinically relevant differences between the statins: implications for therapeutic selection.

Cellular responses to protein overload: key event in renal disease progression.

Matrix metalloproteinase 9 protects mice from anti-glomerular basement membrane nephritis through its fibrinolytic activity.

Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy.

Stimulation of inflammatory responses in vitro and in vivo by lipophilic HMG-CoA reductase inhibitors.

Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome.

P304

1165-1177

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2353/AJPATH.2007.060882

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

170

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Remuzzi

P577

2007-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51376606

http://www.w3.org/2001/XMLSchema#string

P698

17392157

http://www.w3.org/2001/XMLSchema#string

P932

1829451

http://www.w3.org/2001/XMLSchema#string